Differences between perspectives of physicians and patients on anticoagulation in patients with atrial fibrillation: observational studyCommentary: Varied preferences …

…, W Putnam, GJ Flowerdew, BF Brownell, S Nagpal… - Bmj, 2001 - bmj.com
Objective: To determine and compare physicians' and patients' thresholds for how much
reduction in risk of stroke is necessary and how much risk of excess bleeding is acceptable with …

The role of BCNU polymer wafers (Gliadel) in the treatment of malignant glioma

S Nagpal - Neurosurgery Clinics, 2012 - neurosurgery.theclinics.com
After surgical removal, direct delivery of anti neoplastic agents to the tumor site is the oldest
strategy of adjuvant cancer therapy. Brachytherapy, the direct delivery of radiation via an …

Brain tumor mutations detected in cerebral spinal fluid

W Pan, W Gu, S Nagpal, MH Gephart… - Clinical …, 2015 - academic.oup.com
BACKGROUND Detecting tumor-derived cell-free DNA (cfDNA) in the blood of brain tumor
patients is challenging, presumably owing to the blood–brain barrier. Cerebral spinal fluid (…

[HTML][HTML] Current state of immunotherapy for treatment of glioblastoma

…, KE Therkelsen, S Ahmad, S Nagpal - Current treatment options …, 2019 - Springer
Opinion statement At this time, there are no FDA-approved immune therapies for
glioblastoma (GBM) despite many unique therapies currently in clinical trials. GBM is a highly …

Central nervous system cancers, version 3.2020, NCCN clinical practice guidelines in oncology

…, JS Loeffler, MM Mrugala, S Nagpal… - Journal of the National …, 2020 - jnccn.org
The NCCN Guidelines for Central Nervous System (CNS) Cancers focus on management of
adult CNS cancers ranging from noninvasive and surgically curable pilocytic astrocytomas …

[HTML][HTML] Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and Sézary syndrome with variable CD30 expression level: a multi-institution …

…, GS Wood, S Li, S Rozati, S Nagpal… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
Purpose In contrast to Hodgkin lymphoma and systemic anaplastic large-cell lymphoma,
CD30 expression of malignant lymphocytes in mycosis fungoides (MF) and Sézary syndrome (…

Cerebral blood flow changes in glioblastoma patients undergoing bevacizumab treatment are seen in both tumor and normal brain

JB Andre, S Nagpal, DS Hippe… - The …, 2015 - journals.sagepub.com
Bevacizumab (BEV) is increasingly used to treat recurrent glioblastoma (GBM) with some
reported improvement in neurocognitive function despite potential neurotoxicities. We …

Radiation therapy for brain metastases: an ASTRO clinical practice guideline

…, MM Kim, R Kotecha, L Kraemer, J Li, S Nagpal… - Practical radiation …, 2022 - Elsevier
Purpose This guideline provides updated evidence-based recommendations addressing
recent developments in the management of patients with brain metastases, including …

NCCN guidelines insights: central nervous system cancers, version 1.2017

…, JS Loeffler, PL Moots, MM Mrugala, S Nagpal… - Journal of the National …, 2017 - jnccn.org
For many years, the diagnosis and classification of gliomas have been based on histology.
Although studies including large populations of patients demonstrated the prognostic value of …

Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases

…, SD Chang, GR Harsh IV, G Li, S Nagpal… - International Journal of …, 2013 - Elsevier
Purpose We sought to determine the risk of leptomeningeal disease (LMD) in patients treated
with stereotactic radiosurgery (SRS) targeting the postsurgical resection cavity of a brain …